The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 7,329,300 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
AADI BIOSCIENCE INC | COM | 00032Q104 | 3,233,750 | 252,046 | SH | SOLE | 252,046 | 0 | 0 | |||
ALLAKOS INC | COM | 01671P100 | 1,292,470 | 153,500 | SH | SOLE | 153,500 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 3,896,758 | 261,703 | SH | SOLE | 261,703 | 0 | 0 | |||
BIOATLA INC | COM | 09077B104 | 2,159,850 | 261,800 | SH | SOLE | 261,800 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 7,495,200 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | |||
CODEXIS INC | COM | 192005106 | 4,461,950 | 957,500 | SH | SOLE | 957,500 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 13,395,600 | 732,000 | SH | SOLE | 732,000 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 11,455,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
EDAP TMS S A | SPONSORED ADR | 268311107 | 3,269,561 | 306,713 | SH | SOLE | 306,713 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 5,465,916 | 611,400 | SH | SOLE | 611,400 | 0 | 0 | |||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 6,119,400 | 2,170,000 | SH | SOLE | 2,170,000 | 0 | 0 | |||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 2,613,120 | 272,200 | SH | SOLE | 272,200 | 0 | 0 | |||
FORTRESS BIOTECH INC | COM | 34960Q109 | 1,342,750 | 2,050,000 | SH | SOLE | 2,050,000 | 0 | 0 | |||
HARROW HEALTH INC | COM | 415858109 | 55,719,000 | 3,775,000 | SH | SOLE | 3,775,000 | 0 | 0 | |||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 2,521,996 | 138,800 | SH | SOLE | 138,800 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 6,240,832 | 923,200 | SH | SOLE | 923,200 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 4,281,994 | 1,206,841 | SH | SOLE | 1,206,841 | 0 | 0 | |||
KEROS THERAPEUTICS INC | COM | 492327101 | 11,428,760 | 238,000 | SH | SOLE | 238,000 | 0 | 0 | |||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 6,442,800 | 1,560,000 | SH | SOLE | 1,560,000 | 0 | 0 | |||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | 3,567,200 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 3,288,276 | 826,200 | SH | SOLE | 826,200 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 2,695,600 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | |||
MODULAR MEDICAL INC | COM NEW | 60785L207 | 490,000 | 245,000 | SH | SOLE | 245,000 | 0 | 0 | |||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 3,209,828 | 896,600 | SH | SOLE | 896,600 | 0 | 0 | |||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 17,070,750 | 6,075,000 | SH | SOLE | 6,075,000 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 4,684,350 | 417,500 | SH | SOLE | 417,500 | 0 | 0 | |||
PROQR THERAPEUTICS NV | SHS EURO | N71542109 | 5,402,000 | 1,460,000 | SH | SOLE | 1,460,000 | 0 | 0 | |||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 7,216,152 | 2,692,594 | SH | SOLE | 2,692,594 | 0 | 0 | |||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 21,403,200 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | |||
STEREOTAXIS INC | COM NEW | 85916J409 | 2,452,950 | 1,185,000 | SH | SOLE | 1,185,000 | 0 | 0 | |||
TELA BIO INC | COM | 872381108 | 23,837,350 | 2,072,813 | SH | SOLE | 2,072,813 | 0 | 0 | |||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 982,872 | 87,600 | SH | SOLE | 87,600 | 0 | 0 | |||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 2,664,300 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | |||
TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 6,839,100 | 4,590,000 | SH | SOLE | 4,590,000 | 0 | 0 | |||
TREVI THERAPEUTICS INC | COM | 89532M101 | 936,050 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | |||
UROGEN PHARMA LTD | COM | M96088105 | 4,334,379 | 488,656 | SH | SOLE | 488,656 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 8,487,150 | 177,000 | SH | SOLE | 177,000 | 0 | 0 | |||
XOMA CORP DEL | COM NEW | 98419J206 | 4,471,200 | 243,000 | SH | SOLE | 243,000 | 0 | 0 | |||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 3,373,450 | 167,500 | SH | SOLE | 167,500 | 0 | 0 |